114 related articles for article (PubMed ID: 19846217)
1. The characteristics and performance of a multifunctional nanoassembly system for the co-delivery of docetaxel and iSur-pDNA in a mouse hepatocellular carcinoma model.
Xu Z; Zhang Z; Chen Y; Chen L; Lin L; Li Y
Biomaterials; 2010 Feb; 31(5):916-22. PubMed ID: 19846217
[TBL] [Abstract][Full Text] [Related]
2. The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma.
Xu Z; Chen L; Gu W; Gao Y; Lin L; Zhang Z; Xi Y; Li Y
Biomaterials; 2009 Jan; 30(2):226-32. PubMed ID: 18851881
[TBL] [Abstract][Full Text] [Related]
3. A multifunctional nano device as non-viral vector for gene delivery: in vitro characteristics and transfection.
Gao Y; Gu W; Chen L; Xu Z; Li Y
J Control Release; 2007 Apr; 118(3):381-8. PubMed ID: 17321625
[TBL] [Abstract][Full Text] [Related]
4. A smart nanoassembly consisting of acid-labile vinyl ether PEG-DOPE and protamine for gene delivery: preparation and in vitro transfection.
Xu Z; Gu W; Chen L; Gao Y; Zhang Z; Li Y
Biomacromolecules; 2008 Nov; 9(11):3119-26. PubMed ID: 18834174
[TBL] [Abstract][Full Text] [Related]
5. Oral delivery of shRNA and siRNA via multifunctional polymeric nanoparticles for synergistic cancer therapy.
Han L; Tang C; Yin C
Biomaterials; 2014 May; 35(15):4589-600. PubMed ID: 24613049
[TBL] [Abstract][Full Text] [Related]
6. "Intelligent" nanoassembly for gene delivery: in vitro transfection and the possible mechanism.
Xu Z; Chen L; Zhang Z; Gu W; Li Y
Int J Pharm; 2010 Jan; 383(1-2):271-6. PubMed ID: 19770027
[TBL] [Abstract][Full Text] [Related]
7. Enhanced antitumor efficacy of folate modified amphiphilic nanoparticles through co-delivery of chemotherapeutic drugs and genes.
Yu B; Tang C; Yin C
Biomaterials; 2014 Aug; 35(24):6369-78. PubMed ID: 24818887
[TBL] [Abstract][Full Text] [Related]
8. Enhanced antitumor efficacy of arginine modified amphiphilic nanoparticles co-delivering doxorubicin and iSur-pDNA via the multiple synergistic effect.
Song Y; Tang C; Yin C
Biomaterials; 2018 Jan; 150():1-13. PubMed ID: 29028548
[TBL] [Abstract][Full Text] [Related]
9. Co-Delivery of Doxorubicin and Survivin shRNA-Expressing Plasmid Via Microenvironment-Responsive Dendritic Mesoporous Silica Nanoparticles for Synergistic Cancer Therapy.
Li Z; Zhang L; Tang C; Yin C
Pharm Res; 2017 Dec; 34(12):2829-2841. PubMed ID: 28948461
[TBL] [Abstract][Full Text] [Related]
10. Tumor specific delivery and therapy by double-targeted nanostructured lipid carriers with anti-VEGFR-2 antibody.
Liu D; Liu F; Liu Z; Wang L; Zhang N
Mol Pharm; 2011 Dec; 8(6):2291-301. PubMed ID: 21923159
[TBL] [Abstract][Full Text] [Related]
11. Targeted nanoassembly loaded with docetaxel improves intracellular drug delivery and efficacy in murine breast cancer model.
Gao Y; Chen L; Gu W; Xi Y; Lin L; Li Y
Mol Pharm; 2008; 5(6):1044-54. PubMed ID: 19434922
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and tissue distribution of docetaxel by liquid chromatography-mass spectrometry: evaluation of folate receptor-targeting amphiphilic copolymer modified nanostructured lipid carrier.
Zhao X; Zhao Y; Geng L; Li X; Wang X; Liu Z; Wang D; Bi K; Chen X
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Dec; 879(31):3721-7. PubMed ID: 22035980
[TBL] [Abstract][Full Text] [Related]
13. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel.
Liu D; Liu Z; Wang L; Zhang C; Zhang N
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):262-9. PubMed ID: 21435845
[TBL] [Abstract][Full Text] [Related]
14. Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles.
Liu Q; Li R; Zhu Z; Qian X; Guan W; Yu L; Yang M; Jiang X; Liu B
Int J Pharm; 2012 Jul; 430(1-2):350-8. PubMed ID: 22525076
[TBL] [Abstract][Full Text] [Related]
15. Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect.
Wiradharma N; Tong YW; Yang YY
Biomaterials; 2009 Jun; 30(17):3100-9. PubMed ID: 19342093
[TBL] [Abstract][Full Text] [Related]
16. TAT modified and lipid - PEI hybrid nanoparticles for co-delivery of docetaxel and pDNA.
Dong S; Zhou X; Yang J
Biomed Pharmacother; 2016 Dec; 84():954-961. PubMed ID: 27764758
[TBL] [Abstract][Full Text] [Related]
17. A cationic prodrug/therapeutic gene nanocomplex for the synergistic treatment of tumors.
Lu X; Wang QQ; Xu FJ; Tang GP; Yang WT
Biomaterials; 2011 Jul; 32(21):4849-56. PubMed ID: 21458064
[TBL] [Abstract][Full Text] [Related]
18. Receptor-mediated gene delivery by folate-poly(ethylene glycol)-grafted-trimethyl chitosan in vitro.
Zheng Y; Song X; He G; Cai Z; Zhou Y; Yu B; Xu J; Wei Y; Hou S
J Drug Target; 2011 Sep; 19(8):647-56. PubMed ID: 20964597
[TBL] [Abstract][Full Text] [Related]
19. Targeted rod-shaped mesoporous silica nanoparticles for the co-delivery of camptothecin and survivin shRNA in to colon adenocarcinoma in vitro and in vivo.
Babaei M; Abnous K; Taghdisi SM; Taghavi S; Sh Saljooghi A; Ramezani M; Alibolandi M
Eur J Pharm Biopharm; 2020 Nov; 156():84-96. PubMed ID: 32882423
[TBL] [Abstract][Full Text] [Related]
20. Intratumoral delivery of docetaxel enhances antitumor activity of Ad-p53 in murine head and neck cancer xenograft model.
Yoo GH; Subramanian G; Ezzat WH; Tulunay OE; Tran VR; Lonardo F; Ensley JF; Kim H; Won J; Stevens T; Zumstein LA; Lin HS
Am J Otolaryngol; 2010; 31(2):78-83. PubMed ID: 20015717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
